21,400
employees
150
countries in which
the Group’s medicines
are distributed
20%
Over 20% of revenue from
brand-name medicines invested
in R&D each year
€ 4.9 billion
euros in revenue in 2021/2022
including €3.7 billion for brand-name medicines and
€1.2 billion for generic activities
4 therapeutic areas
Oncology, Neuroscience,
Immuno-inflammation,
Cardiometabolism
Posts on our social networks
OUR COMMITMENTS
At Servier, we believe that providing future generations with a healthier world is the very essence of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication, and determination.
First and foremost, our conviction embodies patient-centricity, as well as supporting healthcare professionals and the NHS, compliance and our corporate social responsibility.
CLINICAL TRIALS